Huimin TaoAssociate Director, Analytical Development and Operations at Novartis Gene TherapiesSpeaker
|Huimin Tao has more than 15 years of industry experiences in clinical diagnostics, cell and gene therapies. At Novartis Gene Therapies, she leads analytical development Molecular biology team to support clinical and commercial products through analytical method development, qualification, tech transfer, analytical CMC documentation and response to heathy authority for IND, BLA and PAC. She is the member of the British Pharmacopeia Advanced Therapy Medicinal Products Working Party. Huimin received a master degree in public health from the University of Virginia, and she completed her clinical training as a Neurologist in China with a master degree in medicine from Wuhan University.